Oliver Wyman, a subsidiary of Marsh & McLennan Companies Inc., has announced its agreement to acquire Validate Health, a healthcare analytics business. This acquisition is set to bolster Oliver Wyman Actuarial by integrating advanced analytic and technology solutions that aid healthcare providers and Accountable Care Organizations in managing costs, risk, and performance. The transaction, expected to close in summer 2025, aims to enhance client services, improve market growth, and optimize healthcare programs, ultimately benefiting patient outcomes. Andrew Webster, Co-Founder of Validate Health, expressed optimism about the partnership, highlighting the potential to advance their mission of improving healthcare through data.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.